Double maintains 1 strategies that include EYPT - EyePoint Pharmaceuticals, Inc.
Current Value
$9.271 Year Return
Current Value
$9.271 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -18.20% | $24.29B | +35.36% | 1.09% |
| ED | -14.83% | $36.31B | +13.27% | 3.35% |
| PM | -10.95% | $276.33B | +74.67% | 3.05% |
| LITB | -9.74% | $22.07M | -77.41% | 0.00% |
| AEP | -9.61% | $55.76B | +19.14% | 3.55% |
| EXC | -9.35% | $43.82B | +25.72% | 3.63% |
| MO | -8.84% | $97.93B | +26.25% | 6.95% |
| K | -8.68% | $27.71B | +40.85% | 2.85% |
| DUK | -7.82% | $92.39B | +19.10% | 3.55% |
| LRN | -7.67% | $6.16B | +105.86% | 0.00% |
| T | -7.66% | $207.81B | +53.45% | 3.83% |
| CME | -7.12% | $99.25B | +39.75% | 3.87% |
| KMB | -7.11% | $43.67B | -4.62% | 3.76% |
| FE | -7.01% | $23.31B | +5.57% | 4.29% |
| PPL | -6.23% | $25.13B | +23.96% | 3.15% |
| WEC | -5.69% | $33.43B | +34.23% | 3.33% |
| VSA | -5.58% | $8.76M | -18.25% | 0.00% |
| AWK | -5.13% | $27.80B | +10.98% | 2.21% |
| SO | -4.97% | $101.44B | +19.02% | 3.16% |
| DOGZ | -4.26% | $162.32M | -27.35% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SJM | -<0.01% | $10.96B | -6.96% | 4.20% |
| MSIF | -0.02% | $756.27M | +33.83% | 7.70% |
| PEP | 0.04% | $185.45B | -17.31% | 4.04% |
| LNT | 0.21% | $15.76B | +20.08% | 3.24% |
| POST | 0.24% | $6.21B | +6.88% | 0.00% |
| CCI | -0.27% | $45.17B | +8.85% | 5.55% |
| ACI | 0.33% | $12.20B | +8.96% | 2.48% |
| HSY | 0.35% | $35.62B | -4.79% | 3.11% |
| TEF | 0.35% | $30.02B | +27.27% | 6.13% |
| HUSA | -0.38% | $21.26M | -8.69% | 0.00% |
| HRB | -0.48% | $7.47B | +1.23% | 2.70% |
| MDLZ | -0.49% | $89.29B | +4.44% | 2.72% |
| PSQH | -0.56% | $97.45M | -38.51% | 0.00% |
| PULM | -0.57% | $24.14M | +230.50% | 0.00% |
| EVRG | 0.59% | $15.98B | +31.58% | 3.83% |
| CYCN | 0.71% | $9.95M | +33.33% | 0.00% |
| HRL | -0.72% | $16.88B | +0.49% | 3.72% |
| AGRO | 0.73% | $919.94M | -6.50% | 3.80% |
| ACGL | 0.77% | $34.29B | -3.78% | 0.00% |
| NOC | 0.78% | $72.47B | +15.13% | 1.72% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| OCUL | 63.37% | $1.45B | +36.23% | 0.00% |
| BEAM | 54.47% | $1.76B | -22.33% | 0.00% |
| RXRX | 53.31% | $2.09B | -28.35% | 0.00% |
| CRSP | 53.08% | $4.19B | -8.67% | 0.00% |
| ABCL | 51.94% | $1.04B | +25.99% | 0.00% |
| NTLA | 51.61% | $1.02B | -55.40% | 0.00% |
| DNLI | 51.50% | $2.03B | -35.83% | 0.00% |
| ALEC | 47.16% | $141.99M | -67.28% | 0.00% |
| NNOX | 45.74% | $326.14M | -25.33% | 0.00% |
| IDYA | 45.55% | $1.85B | -37.37% | 0.00% |
| ATXS | 44.78% | $306.44M | -39.46% | 0.00% |
| ARCT | 44.33% | $352.30M | -39.53% | 0.00% |
| IGMS | 44.05% | $77.55M | -79.84% | 0.00% |
| CGEM | 43.94% | $450.87M | -53.16% | 0.00% |
| DNA | 43.78% | $630.84M | -18.04% | 0.00% |
| CLDX | 43.54% | $1.41B | -42.69% | 0.00% |
| SYRE | 43.50% | $934.88M | -34.89% | 0.00% |
| IMNM | 43.07% | $736.56M | -27.65% | 0.00% |
| CGON | 42.89% | $2.01B | -15.87% | 0.00% |
| ARWR | 42.81% | $2.22B | -36.20% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -31.80% | $295.67M | 1.43% |
| TAIL | -29.16% | $99.49M | 0.59% |
| VIXY | -28.18% | $165.58M | 0.85% |
| ULST | -21.54% | $658.54M | 0.2% |
| UNG | -14.59% | $388.31M | 1.06% |
| IVOL | -14.20% | $348.25M | 1.02% |
| XONE | -14.08% | $585.85M | 0.03% |
| BUXX | -14.03% | $324.81M | 0.25% |
| SPTS | -13.27% | $5.77B | 0.03% |
| UTWO | -12.46% | $379.27M | 0.15% |
| SCHO | -12.44% | $11.46B | 0.03% |
| IBTG | -12.35% | $1.92B | 0.07% |
| FXY | -12.24% | $820.31M | 0.4% |
| IBTH | -12.22% | $1.60B | 0.07% |
| STPZ | -12.22% | $450.05M | 0.2% |
| TPMN | -11.98% | $30.70M | 0.65% |
| FTSD | -11.78% | $231.68M | 0.25% |
| AGZ | -11.35% | $613.46M | 0.2% |
| LDUR | -11.22% | $929.45M | 0.5% |
| FTSM | -11.21% | $6.39B | 0.45% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| MEAR | -0.01% | $1.13B | 0.25% |
| CANE | 0.03% | $10.58M | 0.29% |
| NUAG | -0.04% | $58.63M | 0.19% |
| GTO | 0.09% | $1.96B | 0.35% |
| BSCT | 0.09% | $2.10B | 0.1% |
| IBMO | -0.10% | $526.03M | 0.18% |
| AVIG | -0.14% | $1.10B | 0.15% |
| TFI | -0.14% | $3.21B | 0.23% |
| IBDQ | -0.15% | $2.99B | 0.1% |
| SOYB | 0.15% | $26.59M | 0.22% |
| SPIP | 0.16% | $972.34M | 0.12% |
| SPSK | 0.16% | $320.87M | 0.5% |
| DFCF | -0.17% | $7.06B | 0.17% |
| UGA | 0.18% | $72.22M | 0.97% |
| LTPZ | -0.22% | $669.63M | 0.2% |
| BWX | -0.24% | $1.53B | 0.35% |
| IBDR | 0.25% | $3.34B | 0.1% |
| FISR | 0.26% | $428.82M | 0.5% |
| JSI | 0.31% | $865.26M | 0.49% |
| SLQD | -0.31% | $2.28B | 0.06% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 57.62% | $44.38M | 0.5% |
| XBI | 57.10% | $4.84B | 0.35% |
| ARKG | 56.31% | $1.02B | 0.75% |
| IBB | 49.91% | $5.28B | 0.45% |
| IWC | 49.81% | $817.74M | 0.6% |
| IWO | 47.05% | $11.53B | 0.24% |
| PBE | 46.96% | $223.86M | 0.58% |
| PTH | 46.92% | $100.70M | 0.6% |
| XPH | 46.72% | $148.46M | 0.35% |
| IWM | 45.55% | $63.18B | 0.19% |
| VTWO | 45.38% | $12.58B | 0.07% |
| KJAN | 44.87% | $287.49M | 0.79% |
| PBW | 44.13% | $268.39M | 0.65% |
| KOMP | 43.56% | $2.28B | 0.2% |
| SCHA | 43.46% | $17.26B | 0.04% |
| PINK | 43.06% | $129.96M | 0.5% |
| KJUL | 42.93% | $119.28M | 0.79% |
| GSSC | 42.91% | $560.96M | 0.2% |
| FBT | 42.91% | $1.01B | 0.54% |
| BBH | 42.67% | $329.37M | 0.35% |
Finnhub
EyePoint Pharmaceuticals, Inc. dropped from Russell Microcap Growth Index...
Finnhub
EyePoint Pharmaceuticals, Inc. dropped from Russell 3000E Growth Index...
Finnhub
EyePoint Pharmaceuticals, Inc. dropped from Russell 2500 Growth Index...
Finnhub
EyePoint Pharmaceuticals, Inc. dropped from Russell 3000 Growth Index...
Finnhub
EyePoint Pharmaceuticals, Inc. dropped from Russell Small Cap Comp Growth Index...
Finnhub
EyePoint Pharmaceuticals, Inc. dropped from Russell 2000 Growth Index...
